Even as a newly-supplemented malaria suppressive regimen is evaluated in Vietnam, the search continues for more effective anti-malarial drugs, an Army Medical Corps general told the Congress of Neurological Surgeons. Research has intensified, Brig Gen George J. Hayes, MC, USA, said, as the result of reports from various parts of the world—includnig Vietnam—of strains resistant to established antimalarials. Dapsone, used for more than two decades in treating human leprosy, appeared promising (<i>JAMA</i><b>196</b>: 29 [May 30] 1966) for use against chloroquine-resistant<i>Plasmodium falciparum malaria</i>, Brig Gen Hayes noted, continuing: "Accordingly, a controlled field study was conducted in Vietnam during March and April. "This revealed that continuous supplemental, daily, oral administration of one 25 mg tablet of dapsone to troops exposed to malaria in Vietnam can bring about a 50% reduction in the case rates." <h3>Reduced Relapse Rate</h3> By giving the same dosage of dapsone for 28 days during convalescence, starting